Nudge
CompanyAnnouncing our $100M Series A Led by Thrive Capital and Greenoaks
About half of all people will experience a neurological or psychiatric disorder in their lifetime.1 While we’ve made significant advances in treating infectious diseases, cancer, and cardiovascular conditions, progress in brain health has lagged far behind. These disorders, like addiction, chr
Date
Jul 22, 2025
Category
biotech
Lead investor
Thrive Capital
Stage
Series A
Size
$100M
Dylan Field
Starship Ventures
Balderton Capital
Flume Ventures
Y Combinator
General Catalyst
Felicis
Stage 2 Capital
Emergence Capital
Notable Capital
Accel